Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial
Journal of Wound Care · 2024
DOI: 10.12968/jowc.2024.0139 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Wound Care, 2024. Verfasst von Shawn M Cazzell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Limb Preservation Platform, Inc., Fresno, CA, US. Hauptthemen laut MEDLINE: Diabetic Foot, Amnion, Chorion, Standard of Care. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Objective
Diabetic foot ulcers (DFUs) continue to challenge wound care practitioners. This prospective, multicentre, randomised controlled trial (RCT) evaluated the effectiveness of a dehydrated Amnion Chorion Membrane (dACM) (Organogenesis Inc., US) versus standard of care (SoC) alone in complex DFUs in a challenging patient population.
Method
Subjects with a DFU extending into dermis, subcutaneous tissue, tendon, capsule, bone or joint were enrolled in a 12-week trial. They were allocated equally to two treatment groups: dACM (plus SoC); or SoC alone. The primary endpoint was frequency of wound closure determined by a Cox analysis that adjusted for duration and wound area. Kaplan–Meier analysis was used to determine median time to complete wound closure (CWC).
Results
The cohort comprised 218 patients, and these were split equally between the two treatment groups with 109 patients in each. A Cox analysis showed that the estimated frequency of wound closure for the dACM plus SoC group was statistically superior to the SoC alone group at week 4 (12% versus 8%), week 6 (22% versus 11%), week 8 (31% versus 21%), week 10 (42% versus 27%) and week 12 (50% versus 35%), respectively (p=0.04). The computed hazard ratio (1.48 (confidence interval: 0.95, 2.29) showed a 48% greater probability of wound closure in favour of the dACM group. Median time to wound closure for dACM-treated ulcers was 84 days compared to ‘not achieved’ in the SoC-treated group (i.e., ≥50% of SoC-treated DFUs failed to heal by week 12; p=0.04).
Conclusion
In an adequately powered DFU RCT, dACM increased the frequency, decreased the median time, and improved the probability of CWC when compared with SoC alone. dACM demonstrated beneficial effects in DFUs in a complex patient population. Declaration of interest: This study was funded by Organogenesis Inc., US. JC serves as a consultant and speaker for Organogenesis. RDD serves as a speaker for Organogenesis. OMA and MLS serve as consultants for Organogenesis. The authors have no other conflicts of interest to declare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Limb Preservation Platform, Inc., Fresno, CA, US.
- Futuro Clinical Trials, McAllen, TX, US.
- ILD Research Center, Vista, CA, US.
- St. Vincent's Medical Center, Bridgeport, CT, US.
- Department of Surgery, Division of Plastic Surgery, Rutgers NJMS, Newark, NJ, US.
- Sabolinski LLC, Franklin, MA, US.
Zitieren
APA
Cazzell, S. M., Caporusso, J., Vayser, D., Davis, R. D., Alvarez, O. M., & Sabolinski, M. L. (2024). Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial. Journal of Wound Care. https://doi.org/10.12968/jowc.2024.0139
Vancouver
Cazzell SM, Caporusso J, Vayser D, Davis RD, Alvarez OM, Sabolinski ML. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial. Journal of Wound Care. 2024. doi:10.12968/jowc.2024.0139
BibTeX
@article{Cazzell2024,
author = {Cazzell, Shawn M and Caporusso, Joseph and Vayser, Dean and Davis, R Daniel and Alvarez, Oscar M and Sabolinski, Michael L},
title = {Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial},
journal = {Journal of Wound Care},
year = {2024},
doi = {10.12968/jowc.2024.0139}
}
EUVIMED